IQVIA Holdings Inc. Stock
€204.70
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for IQVIA
sharewise wants to provide you with the best news and tools for IQVIA, so we directly link to the best financial data sources.
Financials
News
Elite Pharmaceuticals Q1 Earnings Call Highlights
Key Points
- Interested in Elite Pharmaceuticals Inc.? Here are five stocks we like better.
- Steady financial performance: Elite Pharmaceuticals reported fiscal Q1 2027 revenue of $32.4 million
Novo Nordisk A/S Q2 Earnings Call Highlights
Key Points
- Interested in Novo Nordisk A/S? Here are five stocks we like better.
- Novo Nordisk raised its 2026 outlook after a better-than-expected start to the year, reporting Q2 adjusted sales
Nuvation Bio Q2 Earnings Call Highlights
Key Points
- Interested in Nuvation Bio Inc.? Here are five stocks we like better.
- IBTROZI momentum strengthened: Second-quarter revenue reached $31.7 million, including $23.2 million in U.S
IQVIA Q2 Earnings Call Highlights
Key Points
- Interested in IQVIA Holdings Inc.? Here are five stocks we like better.
- IQVIA exceeded Q2 expectations, with revenue up 8.7% to $4.368 billion, adjusted EBITDA rising 9.2% to $994
Q32 Bio’s Bempikibart Shows Durable Hair Regrowth in Phase 2 Alopecia Study
Key Points
- Interested in Q32 Bio Inc.? Here are five stocks we like better.
- Q32 Bio reported positive 36-week Phase 2a results for bempikibart in severe and very severe alopecia areata
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
Key Points
- Interested in Amphastar Pharmaceuticals, Inc.? Here are five stocks we like better.
- Amphastar reaffirmed its expectation for mid- to high-single-digit revenue growth in 2026, with
IQVIA Q1 Earnings Call Highlights
IQVIA (NYSE:IQV) reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing
ANI Pharmaceuticals Q1 Earnings Call Highlights
ANI Pharmaceuticals (NASDAQ:ANIP) reported first-quarter 2026 results that management said show continued progress in its effort to “accelerat[e] our transformation into a leading rare disease
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know
Keriann Cherofsky, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 558 shares on July 29, 2026, for a total value of about $136,827, according to an SEC Form 4 filing.
IQVIA Holdings Inc. is a
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know
Eric Sherbet, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 5,000 shares of common stock on July 29, 2026, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion
Chairman and CEO Ari Bousbib reported a sale of about 106,000 shares of IQVIA Holdings Inc. (NYSE:IQV) for total proceeds of $26.1 million in an SEC Form 4 filing.
Transaction value based on SEC